Detalhe da pesquisa
1.
A DNA methylation fingerprint of 1628 human samples.
Genome Res
; 22(2): 407-19, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21613409
2.
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.
BMC Cancer
; 14: 33, 2014 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24443788
3.
Quantitative analyses of DAPK1 methylation in AML and MDS.
Int J Cancer
; 131(2): E138-42, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21918973
4.
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.
Haematologica
; 97(3): 393-401, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22058219
5.
Comparative Benefit-Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach.
Pain Ther
; 11(1): 73-91, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792789
6.
Array-based DNA methylation profiling in acute myeloid leukaemia.
Br J Haematol
; 155(1): 65-72, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21790528
7.
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML).
Am J Hematol
; 85(7): 477-81, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20575043
8.
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.
Breast Cancer Res
; 11(3): R34, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19527488
9.
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
BMC Cancer
; 9: 173, 2009 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19500415
10.
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia.
Acta Haematol
; 122(4): 216-20, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19887778
11.
Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases.
Onkologie
; 32(7): 400-4, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19556817
12.
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
BMC Cancer
; 8: 154, 2008 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-18513385
13.
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.
Cancer Res
; 66(12): 6361-9, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16778214
14.
Friday leukemia: myth or reality?
Blood
; 115(4): 912, 2010 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20110434
15.
Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response.
Eur J Haematol
; 79(6): 546-9, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17903214
16.
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies.
Oncogene
; 24(30): 4799-805, 2005 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15870703
17.
The fundamental role of epigenetics in hematopoietic malignancies.
Blood Rev
; 20(1): 1-13, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16426940
18.
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.
Cancer Res
; 62(20): 5902-5, 2002 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12384555
19.
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Ann Hematol
; 84 Suppl 1: 39-46, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16231140
20.
Methylation-specific polymerase chain reaction.
Methods Mol Med
; 113: 279-91, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15968111